Oncoheroes Biosciences and the Super Sam Foundation walking together for the pediatric cancer Blog Post

Oncoheroes Biosciences announces the receipt of funding from Super Sam Foundation, a pediatric cancer nonprofit organization. Oncoheroes is a Boston based biotech with its European headquarters at the Barcelona Science Park. The startup was co-founded in 2017 by Ricardo Garcia, a serial entrepreneur from Barcelona, and the Italian scientist Cesare Spadoni, two parents touched by childhood cancer and determined to change the outlook for these young patients.

 

First foal born in Spain using a procedure which enhances reproductive efficiency and genetic preservation in elite animals Blog Post

The first horse conceived as a result of a combination of ovum pick up (OPU) and intracytoplasmic sperm injection (ICSI), two in vitro fertilisation techniques which enhance fertility and enable the genetic preservation of elite animals, has just been born in Catalonia. This birth points to the future of equine assisted reproduction in Spain. It has been made possible by a project carried out entirely in the country led by the Embryotools centre based in the Barcelona Science Park in partnership with CREA Veterinaris and Embriones Equino.

 

The XIII edition of the Board of Trustees of the UB and the FBG Awards is already open Blog Post

The Awards of the Board of Trustees of the University of Barcelona and the Bosch i Gimpera Foundation for the transfer of knowledge and the creation of innovative companies celebrate their thirteenth edition. These awards aim to promote the return to society of the knowledge acquired through study and research, to stress the importance of technology, knowledge, and innovation transfer projects, and to foster the creation of innovative companies and entrepreneurial culture within the UB Group. The Bosch i Gimpera Foundation is the technology transfer office of the UB since 1983 and is based in the Barcelona Science Park.

 

Genesis Biomed to invest an additional €500,000 in 2020 Blog Post

The Genesis Ventures fund, investment vehicle of several family offices managed by the consulting firm Genesis Biomed, based in the Barcelona Science Park, has announced that it will invest an additional €500,000 in the remainder of this year. The new investments will be made in several of the spin-offs of its portfolio of companies dedicated to biomedical research, in a moment of paralysis due to health and social crisis caused by the SARS-CoV-2 coronavirus.

 

EQA develops The Conformity Assessment of Good Practice for Risk Management of COVID-19 Blog Post

EQA, an assessment and certification leading company accredited by ENAC (the Spain national accreditation agency) has developed The Conformity Assessment of Good Practice for Risk Management of COVID-19, as a basis for the progressive return to normality, essential for social and economic recovery. This evaluation is available for all types of facilities and services, whether they continue with their activity or prepare to start it.

 

Researchers identify a molecular auto-control system to avoid an excessive brown adipose tissue activity Blog Post

A scientific team found, lead by Professor Francesc Villarroya, from the Faculty of Biology and the Institute of Biomedicine of the University of Barcelona (IBUB) present in PCB, found a new molecular auto-control system of lipidic metabolism, so far unknown, could help prevent the damaging effects derived from an excessive activation of the brown adipose tissue. The study is published in the journal Nature Communications.

 

The FDA licenses Chemotargets CLARITY platform Blog Post

Chemotargets –a global leader in the development of intelligence platforms and drug design prediction, headquartered in the Barcelona Science Park– has signed a license agreement for its CLARITY® platform with the Food and Drug Administration (FDA) to provide adverse event predictions and mechanistic investigation in public health risk assessments of new drug applications and existing marketed products.